STAT June 3, 2024
Lizzy Lawrence

Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells technology that monitors the heart conditions of critically ill patients.

Edwards had told investors in December 2023 that it planned to spin off the business in order to focus more sharply on addressing structural defects in the heart. BD,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
The capital required for AI-enabled medical devices
Miist Therapeutics Raises $7M to Develop Inhaled Medicines with Physics-Based Approach
70% of People with Diabetes Feel Stigma: Abbott Survey Reveals Challenges
OCT Medical Devices 2025: AI’s value appreciable, yet human touch remains key
GE HealthCare invests $138M in new contrast media manufacturing site amid rising demand

Share This Article